SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
SURPRISE, Ariz., Aug. 27, 2026
SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.
The award was granted under the SenesTech, Inc. 2026 Inducement Plan as a material inducement to Mr. Karabees entering into employment with SenesTech, in accordance with Nasdaq Listing Rule 5635(c)(4).
The inducement award, granted on Aug. 25, 2026, consists of a nonstatutory stock option to purchase 108,470 shares of SenesTech common stock at an exercise price of $1.19 per share, equal to the fair market value of the Company's common stock on the grant date.
The option will vest and become exercisable in 12 equal quarterly installments measured from a vesting commencement date of July 1, 2026, subject to Mr. Karabees' continued service with the Company through each applicable vesting date. The option will be fully vested and exercisable on the third anniversary of the vesting commencement date.
The award was approved by unanimous written consent of the Company's Board of Directors, a majority of whose members are independent directors under Nasdaq listing standards.
About SenesTech
SenesTech is the leader in rodent birth control and sustainable rodent population management, with a mission to support a healthier environment through the responsible management of animal pest populations. The Company's Evolve® and ContraPest® fertility control solutions, along with its assessment and monitoring services, target reproduction to help reduce rodent populations. SenesTech serves consumer and professional markets with proven approaches that can be used independently or as part of an integrated pest management (IPM) program.
CONTACT:
Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143
SOURCE SenesTech, Inc.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
These Overvalued Stocks Have Plenty of Room to Fall
United States